tert-Butyl (2-(4-bromo-1H-pyrazol-1-yl)ethyl)(methyl)carbamate

Catalog No. :
ACBXWQ510
CAS No. :
877399-67-2
Molecular Formula :
C11H18BrN3O2
Molecular Weight :
304.19

IUPAC Name:tert-butyl (2-(4-bromo-1H-pyrazol-1-yl)ethyl)(methyl)carbamate

tert-Butyl (2-(4-bromo-1H-pyrazol-1-yl)ethyl)(methyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$143.00Login to see priceInquiryInquiry
100mg98%$208.00Login to see priceInquiryInquiry
250mg98%$287.00Login to see priceInquiryInquiry
1g98%$678.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (2-(4-bromo-1H-pyrazol-1-yl)ethyl)(methyl)carbamate
IUPAC Nametert-butyl (2-(4-bromo-1H-pyrazol-1-yl)ethyl)(methyl)carbamate
Molecular FormulaC11H18BrN3O2
Molecular Weight304.19
SMILESO=C(OC(C)(C)C)N(CCN1N=CC(Br)=C1)C
InChI KeyYLXHVJPCPLQZLE-UHFFFAOYSA-N
Synonym[2-(4-bromo-pyrazol-1-yl)-ethyl]-methyl-carbamic acid tert-butyl ester;tert-butyl N-[2-(4-bromo-1H-pyrazol-1-yl)ethyl]-N-methylcarb amate;Carbamic acid, [2-(4-bromo-1H-pyrazol-1-yl)ethyl]methyl-, 1,1-dimethylethyl ester;Carbamic acid, [2-(4-bromo-1H-pyrazol-1-yl)ethyl]methyl-, 1,1-dimethylethyl ester (9CI)
CAS No.877399-67-2

Synthetic Route by SureRoute

1. ACBXWQ510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCVRL608 route compound structure diagram
    ACCVRL6082075-45-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBXWQ510 route product structure diagram
    ACBXWQ510877399-67-2
Inquiry

2. ACBXWQ510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCVRL608 route compound structure diagram
    ACCVRL6082075-45-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBXWQ510 route product structure diagram
    ACBXWQ510877399-67-2
Inquiry

Comments (0)